Original article
Discriminative stimulus properties of dextromethorphan in rats

https://doi.org/10.1016/0753-3322(96)82690-4Get rights and content

Summary

Male Sprague-Dawley rats were trained to discriminate dextromethorphan (DM, 30 mg/kg, ip) from saline using a standard two-lever, fixed ratio 10, food reinforcement procedure. The DM-saline discrimination was acquired, and a range of doses of DM produced a dose-related generalization to the DM-lever choice. Stimulus generalization tests were conducted with dextrorphan, an active metabolite of DM, and with drugs selected from different pharmacological families. Dextrorphan induced a full generalization to DM, but only at a dose higher than the DM training dose. Morphine, a μ opiate receptors agonist, and U 50488, a K opiate receptors agonist, failed to substitute for DM. Cyclazocine, a benzomorphan derivative, with high affinity for sigma receptors, was able to produce a complete generalization to DM, without a change in the number of rats responding. Dizocilpine (MK 801), a phencyclidine-like drug, produced a complete generalization, but only at a dose that markedly reduced the number of rats responding. Carbetapentane and caramiphen, antitussive drugs with high affinity for the ‘specific DM receptors’, failed to substitute for DM. These results show that the discriminative stimulus of DM, did not result primarily from its metabolism to dextrorphan; and the discriminative stimulus properties of DM appear to more closely resemble those of cyclazocine than those of the other drugs tested. This suggests a role of sigma receptors in the mediation of the DM stimulus. These experimental data are discussed with reference to the cyclazocine-like subjective effects produced in man by large doses of DM.

References (59)

  • TricklebankMD et al.

    Mediation of the discriminative stimulus properties of 8-hydroxy-2- (di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor

    Eur J Pharmacol

    (1987)
  • TricklebankMD et al.

    A role for receptors of N-methyl-D-aspartic acid in the discriminative stimulus properties of phencyclidine

    Eur J Pharmacol

    (1987)
  • TricklebankMD et al.

    The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

    Eur J Pharmacol

    (1989)
  • ZyssetT et al.

    In vivo and in vitro dextromethorphan metabolism in SD and DA rat

    Biochem Pharmacol

    (1988)
  • AramJA et al.

    Neocortical epileptogenesis in vitro: studies with N-Methyl-D-Aspartate, phencyclidine, sigma and dextromethorphan receptor ligands

    J Pharmacol Exp Ther

    (1989)
  • BemJL et al.

    Dextromethorphan. An overview of safety issues

    Drug Safety

    (1992)
  • BensonWM et al.

    Comparative pharmacology of levorphan, racemorphan and dextrorphan and related methyl ethers

    J Pharmacol Exp Ther

    (1953)
  • BevanKA et al.

    Mechanism of the anticonvulsant action of dextromethorphan analogues in rat brain

    Br J Pharmacol

    (1992)
  • CharH et al.

    Nasal delivery of [14C]Dextromethorphan hydrochloride in rats: levels in plasma and brain

    J Pharm Sci

    (1991)
  • ChurchJ et al.

    Antitussive agents as N-methyl-aspartate antagonists: further studies

    Can J Physiol Pharmacol

    (1989)
  • ChurchJ et al.

    Cyclazocine and pentazocine as N-methylaspartate antagonists on cat and rat spinal neurons in vivo

    J Pharmacol Exp Ther

    (1990)
  • ColpaertFC et al.

    A drug discrimination analysis of lysergic acid diethylamide (LSD) : in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist

    J Pharmacol Exp Ther

    (1982)
  • CravisioGL et al.

    High affinity dextromethorphan binding sites in guinea pig brain. I Initial characterization

    Mol Pharmacol

    (1983)
  • CravisioGL et al.

    High affinity dextromethorphan binding sites in guinea pig brain. II Competition experiments

    Mol Pharmacol

    (1983)
  • DoddsA et al.

    Toxic psychosis due to dextromethorphan

    Med J Aust

    (1967)
  • DownesCP et al.

    A comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes

    Br J Pharmacol

    (1986)
  • EddyNB et al.

    Synthetic substances with morphine-like effect. Clinical experience: potency side-effects addiction liability Dextromethorphan (D-3-methoxy-N-methylmorphinan)

    Bull WHO

    (1957)
  • EddyNB et al.

    Codeine and its alternates for pain and cough relief. 4. Potential alternates for cough relief. Dextromethorphan

    Bull WHO

    (1969)
  • FlemingPM

    Dependence on dextromethorphan hydrobromide

    Br Med J

    (1986)
  • Cited by (10)

    • Assessment of the rapid and sustained antidepressant-like effects of dextromethorphan in mice

      2020, Pharmacology Biochemistry and Behavior
      Citation Excerpt :

      However, DM abuse (“Robotripping”) has been well documented at doses significantly higher than the antidepressant dose (30–45 mg vs. 200–1500 mg) (Antoniou and Juurlink, 2014; Boyer, 2004; Falck et al., 2006). Preclinical animal studies have found that DM produces a place preference and shares discriminative stimulus properties with the noncompetitive NMDA receptor antagonists PCP and dizocilpine (MK-801) (Gavend et al., 1995; Holtzman, 1994; Shin et al., 2005). Interestingly, the abuse-related effects found in preclinical studies are at the same doses (30 mg/kg) that produce the antidepressant-like effects.

    • Dextromethorphan-induced psychotoxic behaviors cause sexual dysfunction in male mice via stimulation of σ-1 receptors

      2012, Neurochemistry International
      Citation Excerpt :

      Nevertheless, there are several concerns about use of DM because numerous cases of abuse, including drug-seeking behavior, have been reported globally since the 1960s (Chung et al., 2004; McCarthy, 1971; Murray and Brewerton, 1993; Noonan et al., 2000; Rammer et al., 1988; Schwartz, 2005; Wolfe and Caravati, 1995). DM is primarily metabolized in vivo to dextrorphan (DX) by O-demethylation (Schadel et al., 1995); however, we and others have reported that DX is not essential for the neuroprotective action, and DM itself has effects (Gavend et al., 1995; Kim et al., 2003a; Tortella et al., 1989). DM has a higher affinity than DX at [3H] DM binding sites (presumably sigma (σ) sites) but has a lower affinity than DX at DX binding sites (presumably phencyclidine (PCP) sites (Craviso and Musacchio, 1983; Shin et al., 2011, 2010, 2008; Tortella et al., 1989).

    • Social reward-conditioned place preference: A model revealing an interaction between cocaine and social context rewards in rats

      2008, Drug and Alcohol Dependence
      Citation Excerpt :

      Additionally, the results of Experiments 6 and 7 suggest that it is the rewarding effects of cocaine, rather than non-specific psychoactive stimulus effects, that mediate the enhancement of social reward-CPP. Specifically, we demonstrated that dextromethorphan failed to interact with social reward to produce a CPP despite its ability to produce discriminative stimulus effects (Holtzman, 1994; Gavend et al., 1995) and the present findings that it attenuated play behaviors and locomotor activity. Further research is needed to draw firm conclusions regarding the precise nature of the interaction between drug and social rewards; however in any case, these findings have important implications for understanding drug abuse given that many adolescents first begin to experiment with drugs while in a social setting.

    View all citing articles on Scopus
    View full text